On Monday, March 5th, iCAD, an artificial intelligence company, developed a partnership with Karolinska. This partnership expands on an existing agreement between the two companies that will be able to provide AI assistance to scan mammography images. This program shows promise in developing an individualized way to scan for the potential to develop breast cancer in the future.

Breast cancer is the most prevalent cancer in all women. The key to stopping and treating breast cancer depends on how early you can catch it. This makes screening and early detection a major key to preventing breast cancer. The model that is being produced by this partnership shows promise in providing individualized screening for each person. Turning the current model of age based screening on its head. Instead replacing this with a means of risk related screening. They accomplish this based off of mammography images.  Per Hall, professor and senior physician at the Karolinska Institutet says that, “Most current risk models are population-based and focus on lifetime or long-term risk. Our research using the iCAD AI technology has shown that by simply using the information available in the mammogram images, we can more accurately stratify women based on short-term risk. Understanding short-term risk will open the door to new paradigms in both the prevention and treatment of breast cancer.” We can expect to see this form of detection soon under the name ProFound AI.